None listed
Conditions
Interventions
Intervention1: Skinthol Soap: Topical cleansing soap to be used once daily (morning and evening) on face or designated area for 14 days
Control Intervention1: Not Applicable: This is an open-label, si
Sponsors
SKINOVATE LASER COSMETIC SURGERY CENTRE
Eligibility
Inclusion criteria
Inclusion criteria: Healthy male and female subjects aged 18 to 65 years No active dermatological conditions Medically stable with no clinically significant abnormalities Subjects with minimal oily oily or combination skin types Fitzpatrick skin types I to IV
Exclusion criteria
Exclusion criteria: Pregnant or breastfeeding women Individuals with significant dermatological or systemic conditions that may affect study evaluation Subjects with acne having a total lesion count TLC greater than 10 at baseline Subjects with active dermatoses Immunocompromised individuals Subjects with UV triggered skin disorders Subjects with dermatographism Subjects who have used interfering medications such as steroids NSAIDs or antihistamines within the past two weeks Subjects who have used retinoids within the past one month Individuals who have received any vaccination within the last three weeks Individuals with known hypersensitivity to the study product Subjects who have participated in another clinical study within the past 30 days Individuals with a history of substance abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the irritation potential of Skinthol Soap using Draize scoring and patch test evaluationTimepoint: The outcome will be assessed at baseline Day 1 Day 7 and Day 14 | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate non-comedogenicity via lesion count To assess tan removal and skin freshness To evaluate skin scaling (Dermatologist Test DT grading) To assess overall safety and tolerabilityTimepoint: 14 Days | — |
Countries
India
Contacts
Public ContactDr Avinash Bajirao Jadhav
Punawale Multispecialty Hospital
Outcome results
None listed